XUM-28332-09866 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-03
Registered in v-safe
2021-02-03
Dose 1 — Pfizer-BioNTech
2021-02-04
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-10
Health check-in — 7 day, dose 1
Feeling: Good · Headache

Adult check-in
2021-02-17
Health check-in — 14 day, dose 1
Feeling: Good

Adult check-in
2021-02-24
Survey response — 21 day, dose 1
MedDRA: Abdominal pain upper, Headache, Lethargy — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-01
Dose 2 — Pfizer-BioNTech
2021-03-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-03-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-08
Health check-in — 7 day, dose 2
Feeling: Good · Headache

Adult check-in
2021-03-15
Health check-in — 14 day, dose 2
Feeling: Good

Adult check-in
2021-03-24
Survey response — 21 day, dose 2
MedDRA: Fatigue — Feeling: Good

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-29
Survey response — 28 day, dose 2
MedDRA: Dizziness — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-05
Survey response — 35 day, dose 2
MedDRA: Dizziness — Feeling: Good

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-12
Survey response — 42 day, dose 2
MedDRA: Dizziness, Headache — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-05-31
Survey response — 3 month, dose 2
MedDRA: Brain fog, Disturbance in attention, Dizziness, Irritability — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-08-30
Survey response — 6 month, dose 2
MedDRA: Cerebrovascular accident, Dizziness, Magnetic resonance imaging head abnormal, Migraine — Feeling: Fair · Be unable to work or attend school

MedDRA releases: 2021-09,2024-11 · check-in answers available
2022-03-01
Survey response — 12 month, dose 2
MedDRA: Anxiety, Disturbance in attention, Memory impairment, Vision blurred — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

MedDRA releases: 2024-11 · check-in answers available
2022-03-01
Report sent to call center — 12 month, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-03-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-03	Pfizer-BioNTech
2	2021-03-01	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-03-01	Unsuccessful

Free text

Release 4

Symptoms: Headaches, stomach ache, lathagy

Release 6

Symptoms: Tiredness mild

Symptoms: Lightheadedness infrequent

Symptoms: Lightheadedness

Release 7

Symptoms: Sharp headaches and dizziness/ lightheadedness

Release 8

Symptoms: Still dietitian brain fog, dizziness, poor connectedness; poor, poor concentration, irritability. Had covid prior to vaccine. Residual effects and challenges post covid and vaccine

Release 9

Symptoms: Severe dizziness, severe migraines. MRI of the brain resulting in evidence of a minor stroke.

Release 11

Symptoms: Blurred vision, excessive anxiety, hard time focusing and remembering

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain upper	✓	✓	✓
SD	Anxiety	·	·	✓
SD	Brain fog	✓	✓	✓
SD	Cerebrovascular accident	✓	·	✓
SD	Disturbance in attention	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Irritability	✓	✓	✓
SD	Lethargy	✓	✓	✓
SD	Magnetic resonance imaging head abnormal	✓	·	✓
SD	Memory impairment	·	·	✓
SD	Migraine	✓	·	✓
SD	Vision blurred	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release